Monika Chojnacka

6PUBLICATIONS
66CO-AUTHORS
Cancer geneticsEpigenetics (incl. genome methylation and epigenomics)Predictive and prognostic markersMolecular targetsMedical molecular engineering of nucleic acids and proteins
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jun 18, 2025
XPO1 R749Q Mutations Co-occur with POLE Mutations in Cancer and Can Be Targeted to Overcome Chemoresistance.

Tulasigeri M Totiger, Wannasiri Chiraphapphaiboon, Yasmine Baca

|May 10, 2024
The biological and clinical impact of deletions before and after large chromosomal gains in multiple myeloma.

Anthony M Cirrincione, Alexandra M Poos, Bachisio Ziccheddu

|Apr 23, 2024
Genomic Profiling to Contextualize the Results of Intervention for Smoldering Multiple Myeloma.

Dickran Kazandjian, Benjamin Diamond, Marios Papadimitriou

|Nov 09, 2023
Genomic and immune signatures predict clinical outcome in newly diagnosed multiple myeloma treated with immunotherapy regimens.

Francesco Maura, Eileen M Boyle, David Coffey

|Nov 08, 2023
Impact of Rare Structural Variant Events in Newly Diagnosed Multiple Myeloma.

Monika Chojnacka, Benjamin Diamond, Bachisio Ziccheddu

|Aug 31, 2023
Mechanisms of antigen escape from BCMA- or GPRC5D-targeted immunotherapies in multiple myeloma.

Holly Lee, Sungwoo Ahn, Ranjan Maity

Pageof 1

Frequent Collaborators

5 joint publications

Ola Landgren

5 joint publications

Francesco Maura

4 joint publications

Kylee Maclachlan

4 joint publications

Patrick Blaney